Evidence map›Paper›PMID 24358131›Full record

ArticlePloS one2013

A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND).

Farook Thameem, Robert P Igo, Barry I Freedman, Carl Langefeld, Robert L Hanson, Jeffrey R Schelling, Robert C Elston, Ravindranath Duggirala, Susanne B Nicholas, Katrina A B Goddard and 20 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00301249 (The Family Investigation of Nephropathy and Diabetes), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00301249 completednot on this map

The Family Investigation of Nephropathy and Diabetes (FIND) Study

TypeobservationalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran1999 to 2006Enrolled9,031ConditionsDiabetes, Diabetic Nephropathy
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Pathomechanisms of Diabetic Kidney Disease.Journal of clinical medicine · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study.Journal of the American Society of Nephrology : JASN · 2017
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. The genetics of diabetic complications.Nature reviews. Nephrology · 2015
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 15 institutions in 2 countries.

Farook ThameemDepartment of Medicine, The University of Texas Health Science Center, San Antonio, Texas, United States of America.
Robert P IgoDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
Barry I FreedmanDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Carl LangefeldDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Robert L HansonPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
Jeffrey R SchellingDepartment of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America.
Robert C ElstonDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
Ravindranath DuggiralaDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Susanne B NicholasDepartment of Medicine, University of California, Los Angeles, California, United States of America.
Katrina A B GoddardCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, United States of America.
Jasmin DiversDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Xiuqing GuoDepartment of Pediatrics, Harbor-University of California Los Angeles Medical Center, Torrance, California, United States of America.
Eli IppDepartment of Medicine, Harbor-University of California Los Angeles Medical Center, Torrance, California, United States of America.
Paul L KimmelNational Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Lucy A MeoniDepartment of Epidemiology and Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Vallabh O ShahUniversity of New Mexico, Albuquerque, New Mexico, United States of America.
Michael W SmithNational Human Genome Research Institute, NIH, Bethesda, Maryland, United States of America.
Cheryl A WinklerCenter for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland, United States of America.
Philip G ZagerUniversity of New Mexico, Albuquerque, New Mexico, United States of America.
William C KnowlerPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
Robert G NelsonPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America.
Madeline V PahlDepartment of Medicine, University of California, Irvine, California, United States of America.
Rulan S ParekhDepartment of Epidemiology and Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America ; Department of Pediatrics, University of Toronto, Toronto, Canada.
W H Linda KaoDepartment of Epidemiology and Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Rebekah S RasoolyNational Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Sharon G AdlerDepartment of Medicine, Harbor-University of California Los Angeles Medical Center, Torrance, California, United States of America.
Hanna E AbboudDepartment of Medicine, The University of Texas Health Science Center, San Antonio, Texas, United States of America.
Sudha K IyengarDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
John R SedorDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
Family Investigation of Nephropathy and Diabetes Research Group
Case Western Reserve University · USNational Institutes of Health · USWake Forest University · USJohns Hopkins University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USThe University of Texas Health Science Center · USUCLA Medical Center · USUniversity of California, Los Angeles · USUniversity of New Mexico · USKaiser Permanente Center for Health Research · USNational Cancer Institute · USNational Human Genome Research Institute · USTexas Biomedical Research Institute · USUniversity of California, Irvine · USUniversity of Toronto · CA

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
LINKAGE CONSORTIUM FOR END-STAGE RENAL DISEASEU01DK057292 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI IYENGAR, SUDHA K · 1999 to 2009
$13.1M
Epidemiology, Pathophysiology and Treatment of Diabetic NephropathyZIADK069062 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI NELSON, ROBERT G · 2009 to 2023
$10.1M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
Genetics of Renal Disease in African AmericansZIABC010022 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WINKLER, CHERYL · 2009 to 2022
$8.9M
Genetic Epidemiology of Diabetic NephropathyZIADK069094 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANSON, ROBERT · 2009 to 2025
$7.7M
Intramural NIH HHSNCATS NIH HHS UL1 TR000041NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1 TR001449NIDDK NIH HHS P30 DK063491NIDDK NIH HHS U01 DK057292NIDDK NIH HHS U01DK57292-05
6 · The paper itself

Abstract

objectiveEstimated glomerular filtration rate (eGFR), a measure of kidney function, is heritable, suggesting that genes influence renal function. Genes that influence eGFR have been identified through genome-wide association studies. However, family-based linkage approaches may identify loci that explain a larger proportion of the heritability. This study used genome-wide linkage and association scans to identify quantitative trait loci (QTL) that influence eGFR.

methodsGenome-wide linkage and sparse association scans of eGFR were performed in families ascertained by probands with advanced diabetic nephropathy (DN) from the multi-ethnic Family Investigation of Nephropathy and Diabetes (FIND) study. This study included 954 African Americans (AA), 781 American Indians (AI), 614 European Americans (EA) and 1,611 Mexican Americans (MA). A total of 3,960 FIND participants were genotyped for 6,000 single nucleotide polymorphisms (SNPs) using the Illumina Linkage IVb panel. GFR was estimated by the Modification of Diet in Renal Disease (MDRD) formula.

resultsThe non-parametric linkage analysis, accounting for the effects of diabetes duration and BMI, identified the strongest evidence for linkage of eGFR on chromosome 20q11 (log of the odds [LOD] = 3.34; P = 4.4 × 10(-5)) in MA and chromosome 15q12 (LOD = 2.84; P = 1.5 × 10(-4)) in EA. In all subjects, the strongest linkage signal for eGFR was detected on chromosome 10p12 (P = 5.5 × 10(-4)) at 44 cM near marker rs1339048. A subsequent association scan in both ancestry-specific groups and the entire population identified several SNPs significantly associated with eGFR across the genome.

conclusionThe present study describes the localization of QTL influencing eGFR on 20q11 in MA, 15q21 in EA and 10p12 in the combined ethnic groups participating in the FIND study. Identification of causal genes/variants influencing eGFR, within these linkage and association loci, will open new avenues for functional analyses and development of novel diagnostic markers for DN.

Indexed as

Genetic LinkagePolymorphism, Single NucleotideAgedBlack or African AmericanDiabetic NephropathiesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeGlomerular Filtration RateHumansIndians, North AmericanKidney DiseasesMaleMexican AmericansMiddle Aged

Identifiers

PMID24358131
PMCPMC3866106
OpenAlexW2084320878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.